Integrating an AI-Driven Hydronephrosis Decision-Making Tool
Integration of a Hydronephrosis AI-Driven Decision-Making Tool Into Clinical Practice: A Clinical Trial
1 other identifier
interventional
322
0 countries
N/A
Brief Summary
Hydronephrosis is a common congenital kidney anomaly. While most cases resolve on their own, some require surgery. Clinicians rely on repeated ultrasounds and sometimes invasive tests to decide if surgery is needed, but predicting outcomes is difficult. Researchers at SickKids developed an AI model that analyzes ultrasound images to assist in diagnosing and managing hydronephrosis. This study tests how well the AI integrates into real-world care. Clinicians will first make care decisions without AI and then review the AI's prediction before deciding whether to change their plan. A separate expert, unaware of whether AI influenced the first clinician's plan, will make the final decision to ensure care remains unchanged. The study will assess whether AI improves decision-making, reduces unnecessary tests, and fits into clinical workflows. If successful, the AI model could serve as a complementary tool to make diagnoses more efficient and precise while minimizing invasive procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 16, 2026
CompletedFirst Posted
Study publicly available on registry
May 12, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2027
Study Completion
Last participant's last visit for all outcomes
January 31, 2027
May 12, 2026
May 1, 2026
6 months
April 16, 2026
May 6, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Clinician Management Decisions Following Exposure to the AI Model
The proportion of clinician management decisions revised immediately after exposure to the AI model output. Management decisions include: (1) discharge, (2) monitor with ultrasound, (3) additional invasive testing, or (4) referral for surgery.
Immediately after AI model exposure during each case review session, through study completion (average of 6 months)
Secondary Outcomes (2)
Agreement Between Clinician Decisions and Expert Reference Decisions Using Cohen's Kappa
Immediately after clinician review and AI model exposure during each case review session, through study completion (average of 6 months)
Proportion of Management Decision Changes Stratified by Clinician Experience Level
Immediately after AI model exposure during each case review session, through study completion (average of 6 months)
Study Arms (1)
AI Model Intervention Arm
EXPERIMENTALWhen children with HN are seen in clinic, their ultrasound imaging and history will be provided to an initial clinician who will first formulate a plan of care without access to the AI model as per the standard of care. After the initial plan is documented and before discussion with the primary provider, the initial clinician will then be granted access to the AI model, where they can input the ultrasound images and receive the model's prediction. The clinician can choose to modify or maintain their drafted plan based on the model's output. The clinician's final drafted plan will subsequently be discussed with the blinded final clinical expert (primary provider) who will make the final decision to maintain the standard of care for each patient. The final clinical expert will be blinded to whether the initial clinician changed their plan or not given the AI model
Interventions
The AI intervention is a deep learning algorithm used to predict obstructive hydronephrosis. It was developed at SickKids and has recently completed the silent trial phase. This clinical trial aims to validate the model's clinical integration by assessing its impact on clinician decision-making and care plan recommendations. To uphold standard care, a blinded clinician will make final decisions.
Eligibility Criteria
You may qualify if:
- Seen for HN in-person in the Pediatric Urology clinic with ultrasound scans taken at SickKids
- New and follow-up patients 0-24 months.
You may not qualify if:
- Older than 24m
- Concurrent urinary tract anomalies (duplex configurations; PUV etc.)
- History of renal surgical intervention (post-op patients)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- This study will be a partially blinded trial as a third blinded clinician who makes the final clinical decision will be unaware if and what changes were made after clinician exposure to the AI model. Since, standard of care is maintained, patients will not be aware of the impact of the AI model
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Nurse Practitioner
Study Record Dates
First Submitted
April 16, 2026
First Posted
May 12, 2026
Study Start (Estimated)
August 1, 2026
Primary Completion (Estimated)
January 31, 2027
Study Completion (Estimated)
January 31, 2027
Last Updated
May 12, 2026
Record last verified: 2026-05